Bladder cancer: open trials in Belgium

23 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
AZORG Campus Aalst-Moorselbaan, Aalst · AZ Sint-Jan, Brugge (Bruges) · UZ Antwerpen, Edegem · AZ Maria Middelares, Gent (Ghent) · Universitair Ziekenhuis Gasthuisberg, Leuven · Vitaz, Sint-Niklaas · CHU UCL Namur - Site Godinne, Yvoir
Registry updated 2026-11-03
NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hopital Erasme, Anderlecht · AZ ST-JAN Brugge A.V., Brugge · Ziekenhuis Oost-Limburg, Genk · Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-11-03
2024-516906-47-00
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Trial Treatment · Phase 2/3 · Daiichi Sankyo Inc.
Universitair Ziekenhuis Antwerpen, Edegem · Az Maria Middelares Gent, Gent · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège
Registry updated 2026-10-29
NCT07144319
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Research · Photocure
UZ Leuven, Leuven
Registry updated 2026-10-29
NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-29
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Cliniques universitaires Saint-Luc, Brussels · UZA, Edegem · Universitair Ziekenhuis Gent, Ghent · Universitair Ziekenhuis Brussel, Jette · UZ Leuven, Leuven
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-26
2024-518348-19-00
A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
Trial Treatment · Phase 1 · Novartis Pharma AG
Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-21
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Algemeen Ziekenhuis Groeninge, Kortrijk
Registry updated 2026-10-01
NCT06990061
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Institut Jules Bordet, Anderlecht · Cliniques universitaires Saint-Luc, Brussels · Ziekenhuis aan de Stroom, Wilrijk
Registry updated 2026-09-11
NCT05303532
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
Trial Treatment · Phase 3 · Astrazeneca AB
Grand Hopital de Charleroi, Charleroi
Registry updated 2026-09-08
NCT06644755
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · Daiichi Sankyo
UZ Leuven Europe Leuven, Leuven
Registry updated 2026-09-04
NCT07758881
Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC.
Trial Treatment · Eight Medical International BV
AZ Sint-Jan, Campus Sint-Jan, Bruges · AZ Delta, Roeselare
Registry updated 2026-08-14
NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · Lumara Bio Oncologics GmbH
Institut Jules Bordet, Anderlecht · UZ Leuven, Leuven
Registry updated 2026-08-11
NCT07756437
Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer
Research · AZ Sint-Lucas Gent
AZ Sint-Lucas Gent, Ghent
Registry updated 2026-08-10
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
UZ Gent, Ghent · AZ Maria Middelares, Ghent · Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège · ZAS Augustinus, Wilrijk
Registry updated 2026-07-29
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Trial Treatment · Phase 2 · Seagen, a wholly owned subsidiary of Pfizer
Az Maria Middelares Gent, Gent · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur
Registry updated 2026-07-22
NCT05642780
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Trial Treatment · Phase 2 · Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
AZ KLINA, Brasschaat · Grand Hopital de Charleroi, Charleroi · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-05-19
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Research · UMC Utrecht
Insitut Jules Bordet, Brussels
Registry updated 2026-03-05
NCT04724928
Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · University Hospital, Ghent
Ghent university hospital, Ghent
Registry updated 2025-01-15
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Institut Jules Bordet, Anderlecht · Universitair Ziekenhuis Gent, Ghent · Gasthuiszusters Antwerpen - Sint-Augustinus, Wilrijk
Registry updated 2024-08-26
NCT03973671
Prospective Sample Collection for Cancer of Bladder
Research · Universitaire Ziekenhuizen KU Leuven
University Hospitals Leuven, Leuven
Registry updated 2024-03-28

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error